NL-OMON34100
Withdrawn
Not Applicable
Diagnostic measure of atrial fibrillation on patients at outpatient TIA-clinic - TIA-AF-project
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- atrial fibrillation and ischemic stroke
- Sponsor
- Sint Antonius Ziekenhuis
- Enrollment
- 50
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ischemic stroke (CVA or TIA)
- •signs and symptoms of atrial fibrillation
- •left atrial enlargement at ECG
- •left ventricle hypertrophy at ECG
- •premature atrial complex at ECG
- •hyperthyreoidie
- •ischemic attacks in several cerebral flow area
Exclusion Criteria
- •atrial fibrillation in history
- •atrial fibrillation registrated at ECG at outpatient clinic neurologie\-TIA
- •hemorragic CVA
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Diagnostic of atrial fibrillation on patients at TIA-clinicatrial fibrillation1000752110007963NL-OMON34477Sint Antonius Ziekenhuis50
Completed
Not Applicable
Detecting and Diagnosing Atrial Fibrillation: enhanced case-finding in patients from general practice and evaluating three ways of irregular pulse detection. A cluster randomised trial with nested diagnostic studiesarrhythmiaAtrial fibrillation1000752110014523NL-OMON45031Academisch Medisch Centrum19,200
Completed
Not Applicable
Atrial fibrillation screening with smartphone ECG: implementation in a primary care settingAtrial FibrillationCardiovascular - Other cardiovascular diseasesPublic Health - Health service researchACTRN12616000850471niversity of Sydney1,806
Completed
Not Applicable
Atrial fibrillation (AF) screening using a smartphone electrocardiogram (ECG): pilot study to test implementation in the primary care setting.Atrial FibrillationCardiovascular - Other cardiovascular diseasesPublic Health - Health service researchACTRN12615000622505niversity of Sydney1,000
Recruiting
Phase 2
Detection and Quantification of Atrial Fibrillation in High-Risk Patients Using a Smartwatch Wearable (Apple Watch) with a Photoplethysmographic sensor and ECG-functionalityarrhythmiaAtrial fibrillation10007521NL-OMON56124Academisch Medisch Centrum436